Business Daily Media

Men's Weekly

.

Zuellig Pharma and Institut AllergoSan sign 10-year regional partnership to bring leading probiotic brand OMNi-BiOTiC® to key markets in Asia

New agreement marks major milestone for Zuellig Pharma as it focuses on expanding its consumer healthcare segment, and for Institut AllergoSan as it expands its global presence

SINGAPORE - Media OutReach Newswire - 19 July 2024 - Zuellig Pharma, a leading healthcare solutions company in Asia, today announced that it has signed a 10-year commercialisation partnership with Austria-based Institut AllergoSan, a research and development company that specialises in products made from natural substances such as probiotic bacteria, plant extracts and minerals.

Anita Frauwallner, founder and CEO of Institut AllergoSan (left) and John Graham, Group CEO, Zuellig Pharma (right) at the partnership signing ceremony to bring OMNi-BiOTiC® to key markets in Asia.
Anita Frauwallner, founder and CEO of Institut AllergoSan (left) and John Graham, Group CEO, Zuellig Pharma (right) at the partnership signing ceremony to bring OMNi-BiOTiC® to key markets in Asia.

Under this partnership, Zuellig Pharma will provide a wide spectrum of commercialisation support, including product registration, sales and marketing, and warehousing and distribution services to bring OMNi-BiOTiC®, one of Institut AllergoSan's leading probiotic brands, to key markets in Asia.

"Our consumer healthcare segment will be one of the key growth drivers in our business over the coming years and this partnership represents a significant step forward in our commitment to delivering innovative and accessible healthcare solutions to patients in Asia. With a fast-growing probiotics market in Asia, the comprehensive and tailored solutions offered through our commercialisation division, ZP Therapeutics, will help our partners expand their footprint to meet greater consumer demand for gut health products in this region. Together with Institut AllergoSan, we will leverage our combined expertise to enhance the well-being of consumers and drive forward our mission of making healthcare more accessible," said John Graham, Group CEO, Zuellig Pharma.

"We are dedicated to supporting consumers' pursuit of a healthier, more vital self and offer medically relevant probiotic supplements that target specific health needs and deliver clinically backed results. OMNi-BiOTiC® is the top selling probiotic brand in all German-speaking markets in Europe such as Austria, Germany and Switzerland[1] and we look forward to working closely with Zuellig Pharma to bring these innovative products to everybody in Asia who wants to promote an active, healthy life," adds Anita Frauwallner, founder and CEO of Institut AllergoSan.

Zuellig Pharma plans to launch OMNi-BiOTiC® in Indonesia, the Philippines and Taiwan in 2025, followed by other key markets thereafter.


[1] IQVIA OTC Global Insights 2023, 03F1/A7F, IQVIA OTC Audits / Public Price in EUR.
Hashtag: #ZuelligPharma #InstitutAllergoSan #Healthcare #Probiotics #ConsumerHealthcare #GutHealth #Commercialisation



The issuer is solely responsible for the content of this announcement.

About Zuellig Pharma

Zuellig Pharma is a leading healthcare solutions company in Asia, and our mission is to make healthcare more accessible to the communities we serve. We provide world-class distribution, digital and commercial services to support the growing healthcare needs in this region. The company was started a hundred years ago and has grown to become a multi-billion dollar business covering 16 markets with over 12,000 employees. Our people serve more than 200,000 medical facilities and work with over 450 clients, including the top 20 pharmaceutical companies in the world.

ZP Therapeutics, a division of Zuellig Pharma, is the commercialisation partner of choice for the healthcare industry with offices in 13 countries across Asia and over 2,500 associates. A catalyst in improving patient journeys and healthcare outcomes through commercial excellence, robust in-market capabilities and strong ethical principles, ZP Therapeutics is a trusted partner for expanding patient access and providing innovations to the healthcare community.

For more information, visit:

About Institut AllergoSan

Institut AllergoSan, based in Graz, Austria, was founded in 1991 by a group of integrative doctors and pharmacists together with Anita Frauwallner, who is now the managing director. Since then, the company has been focused on the scientific research and development of products made from natural substances such as probiotic bacteria, dietary fibres, micronutrients, and plant extracts. Through the intensive cooperation between Institut AllergoSan and recognised scientists from the fields of medicine, pharmacy, and biochemistry, it has been possible to build up a recognised research and competence centre focused on the largest organ of the human body - the intestine. This has resulted in the OMNi-BiOTiC®, OMNi-LOGiC® and META-CARE® product range, among others.

It has been a true pioneering spirit that drove Anita Frauwallner to embark on a largely unknown path more than 30 years ago: she has dedicated her life to microbiome research and the development of innovative, high-quality probiotics. This spirit has brought OMNi-BiOTiC® to rank today as number 3 on the global probiotic market and number 1 in German-speaking Europe and numerous other countries.

News from Asia

HDBank: A Leading Vietnamese Bank Named Among ASEAN’s Top 5 in Corporate Governance for 2025

HO CHI MINH CITY, VIETNAM - Media OutReach Newswire - 29 July 2025 - The Ho Chi Minh City Development Commercial Joint Stock Bank (HDBank) has been named one of the Top 5 Vietnamese listed compani...

Octa market outlook: navigating one of the most eventful weeks of the year

KUALA LUMPUR, MALAYSIA - Media OutReach Newswire - 28 July 2025 - Forex traders are bracing for what could be one of the most pivotal trading weeks of the year. The calendar is packed with high-im...

Lee Kum Kee Supports the 2025 Asian Championship of World Chinese Cuisine

Where culinary elites are brought together to celebrate Asian gastronomyHONG KONG, CHINA - Media OutReach Newswire - 29 July 2025 - The 2025 Asian Championship of World Chinese Cuisine, organised ...

OPPO Launches AI Phone Reno14 Series and Upgraded AI-Powered Intelligent After-Sales Service System

SHENZHEN, CHINA - Media OutReach Newswire – 29 July 2025 - Following the recent global launch of the Reno14 Series—the latest OPPO AI phone featuring cutting-edge AI imaging capabilities and trend...

Hong Kong Developed Revolutionary Sauce EXOTICA UMAMI [EX M] Impresses Acclaimed International Chefs

Top Italian Restaurateur Paolo Monti of Hong Kong’s popular AMA Italian Ristorante adds new pork collar meat dish to menu incorporating innovative new seasoning sauceHONG KONG SAR - Media OutReach...

Vinmec Central Park Performs Vietnam’s First SEEG using AutoGuide Robotic Guidance System for a child diagnosed from refractory epilepsy

HO CHI MINH CITY, VIETNAM - Media OutReach Newswire - 29 July 2025 – A major breakthrough in Vietnam's neurological treatment was recently achieved as doctors at Vinmec Central Park Internati...

VinFast joins the Association of Indonesia Automotive Industries

JAKARTA, INDONESIA - Media OutReach Newswire - 25 July 2025 - VinFast officially announced its membership in the Association of Indonesia Automotive Industries (GAIKINDO), marking a significant mi...

XTransfer Announces Over 700,000 Global Customers

Emerging Markets Become the "Blue Ocean" for Enterprises Going GlobalHONG KONG SAR - Media OutReach Newswire - 29 July 2025 - XTransfer, the World's Leading & China's No.1 B2B Cross-Border ...

Chun Wo Innovation Student Awards 2024 Successfully Concluded Four Outstanding Projects Showcase the Future of Engineering Innovation

HONG KONG SAR - Media OutReach Newswire - 29 July 2025 - Organised by Chun Wo Development Holdings Limited ("Chun Wo"), the Chun Wo Innovation Student Awards 2024 ("CWISA") concluded successfull...

HEIDELBERG agrees strategic partnership with defense specialist VINCORION

HEIDELBERG moves into defense industry VINCORION Advanced Systems GmbH specializes in power systems for safety-critical applications HEIDELBERG impres...

Small-Business Cash-Flow Playbook 2025

An educational guide to managing ATO debt, real-time super and growth finance in Australia’s new landscape Why ATO debt just became the most expe...

Landowners Offered $30,000 Per Year for Just 1 Hectare: The Rise of 5MW Battery Projects Across Australia

In a pivotal shift reshaping Australia’s renewable energy landscape, landowners in Queensland, New South Wales, and Victoria are being offered up ...

Major national security tech alliance launches with Aerologix a founding member

Australia’s leading drone intelligence pioneer bolsters sovereign tech power Australia’s leading aerial data and drone intelligence platform, Aer...

Chris Hancock AM Honoured as 2025 Communications Ambassador

SYDNEY Chris Hancock AM, former CEO of AARNet, has been awarded the prestigious Communications Ambassador title at the 2025 Telecommunications Indus...

Baby boomers are driving development feasibility leading to larger apartments

As residential developers continue to grapple with feasibility issues on apartment projects, the sector is struggling to deliver volumes of new st...

Hays launches FY25/26 Salary Guide: ‘Salary Paradox’ deepens as pay rises fail Australians

Rising dissatisfaction with pay, progression and perks is fuelling a new wave of career change in FY25/26, as Australians demand more from employe...

Sell by LayBy